BIOGEN INC. (BIIB) Gross profit 2016–2025
BIOGEN INC. (BIIB) annual gross profit history from SEC filings — each fiscal year as reported.
$7.5BFY2025 · since FY2016: $10.0B → $7.5B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $7.5B | +1.6% |
| FY2024 | $7.4B | +0.9% |
| FY2023 | $7.3B | -7.5% |
| FY2022 | $7.9B | -11.0% |
| FY2021 | $8.9B | -23.8% |
| FY2020 | $11.6B | -6.3% |
| FY2019 | $12.4B | +6.8% |
| FY2018 | $11.6B | +9.3% |
| FY2017 | $10.6B | +6.8% |
| FY2016 | $10.0B | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More BIIB financial trends
BIIB RevenueBIIB Net incomeBIIB Net marginBIIB Gross marginBIIB Operating incomeBIIB Operating marginBIIB Operating cash flowBIIB Free cash flowBIIB Capital expendituresBIIB Return on equityBIIB Stock buybacksBIIB Dividends paidBIIB Total assetsBIIB Total liabilitiesBIIB Shareholders’ equityBIIB overview →